Patent ID: 8829011

Claim:
A compound of Formula (I): wherein m is 1; n is 2; R 1 is —H, —C 1-4 alkyl, or benzyl; R 2 and R 3 are each independently —H, —C 1-4 alkyl, or benzyl; or alternatively, R 2 and R 3 taken together with the nitrogen to which they are attached form a saturated monocyclic heterocycloalkyl ring, unsubstituted or substituted with one or two substitutents selected from —C 1-4 alkyl, —OH, and halo; Ar is a phenyl, monocyclic heteroaryl, or bicyclic heteroaryl ring, unsubstituted or substituted with one or two R i substituents; R i is selected from the group consisting of —C 1-7 alkyl, —C 2-7 alkenyl, —C 2-7 alkynyl, —C 3-7 cycloalkyl, halo, —CF 3 , —OH, —OC 1-7 alkyl, —OCF 3 , —OC 3-7 alkenyl, —OC 3-7 alkynyl, —N(R j )R k , —C(O)N(R j )R k , —N(R j )C(O)R k , —N(R j )SO 2 C 1-6 alkyl, —S(O) 0-2 —C 1-6 alkyl, —SO 2 N(R j )R k , —SCF 3 , —C(O)C 1-6 alkyl, —NO 2 , —CN, —COOH, and —COOC 1-7 alkyl; where R j ; and R k are independently —H or —C 1-4 alkyl; or alternatively, two adjacent R i substituents form —OC 1-4 alkyleneO—, —(CH 2 ) 2-3 NH—, —(CH 2 ) 1-2 NH(CH 2 )—, —(CH 2 ) 2-3 N(C 1-4 alkyl)-, or —(CH 2 ) 1-2 N(C 1-4 alkyl)(CH 2 )—; or a stereoisomeric form, hydrate, solvate, a pharmaceutically acceptable salt-thereof.